猪α型干扰素基因在毕赤酵母中的分泌表达
摘要
干扰素(IFN)是一类重要的细胞因子，具种属特异性，在同种细胞上具有广谱的抗病毒、抗细胞增殖、免疫调节等多种生物活性，研究表明，利用干扰素防治家畜的病毒性疾病是一种理想的治疗方式。但是，动物体内一般情况下不产生干扰素，国内外学者曾尝试利用病毒感染诱导动物机体白细胞产生干扰素，结果仅产生极其微量的IFN且生产成本高，难于提取纯化。随着DNA重组技术的发展，国内外亦有利用原核表达系统表达重组IFN蛋白的报道，但表达的目的蛋白常以包涵体形式存在，提取纯化操作步骤复杂、蛋白活性不高。鉴于以上研究现状，本研究首次尝试利用真核表达系统表达猪α干扰素重组蛋白。
近年来，甲醇营养型酵母表达系统的研究得到迅速发展，因其具有高表达、高稳定、高分泌、能对表达的外源蛋白进行正确的折叠、加工，利于下游分离纯化操作、能大规模发酵生产等诸多优点，国内外已经利用此系统表达了多种对人类有益的动植物及微生物活性蛋白，但对猪α型干扰素的酵母表达还未见报导，本研究是国内外首次采用此系统表达猪α型干扰素。
本研究以猪α干扰素重组质粒PGEX-IFN为模板，运用常规PCR方法扩增得到猪α干扰素基因的成熟编码序列。将此基因与毕赤酵母分泌型表达载体pPICZαA连接，构建pPICZαA-IFN重组质粒，并用常规CaCl_2法转化大肠杆菌JM109进行扩增。提取重组质粒，酶切、PCR扩增和DNA序列分析鉴定阳性克隆。阳性重组质粒经纯化处理后用BioRad公司电转仪电转化毕赤酵母菌株KM71H。抗生素Zeocin~(TM)浓度梯度筛选高拷贝菌株，分别提取这些高拷贝菌株的基因组DNA，以此为模板做PCR反应鉴定阳性克隆。经上述实验过程筛选出的高拷贝重组菌株分别通过BMGY／BMMY培养基和YPG培养基、用甲醇诱导表达，诱导菌液上清
葛丽：猪a干扰素基因在毕赤酵母中的分泌表达
通过三氯醋酸沉淀蛋白处理，做 SDS－PAGE和 West。印迹实验，结果表
明表达产物为重组猪口干扰素融合蛋白。将筛选出来的重组菌株诱导144
小时，取菌液上清液用VSV／WISH系统检测重组蛋白的抗病毒活性为
4．l＊I04lU／ffiL o
Interferon (IFN), a family of cytokines, have activities on interfering with the replication of various viruses, decreasing cell proliferation and modifying immunological processes. The research about IFN indicates, it is a kind of ideal therapy that IFN act on healthy or unhealthy animals to prevent or cure many kinds of diseases infected by virus. However, animal organisms could not produce IFN commonly, many scholars had attempted to use virus infect animals in order to induce leukocyte to produce IFN. As a result, a very small quantity of IFN was produced and also the cost of production was very high, it was difficult to extract and purify IFN protein. With the development of DNA recombination technology, there are also some reports about the expression of recombined IFN protein by prokaryotic expression system, but the expressed
proteins often consist in the form of inclusion body= The operations about extracting and purifying proteins are very complicated, biological activity of proteins are not high. Therefore, this research is the first time to attempt to express porcine IFN-a(PoIFN-a) by eukaryotic expression system.
Recently, the expression system of methylotrophic yeast has been developed quickly. As a result of its many advantages, such as high expression, high stability, high secretion and so on, many kinds of Protein, including animal, plant, microorganism proteins, have been expressed by this system in the world, but we have not seen any report about yeast expression of PoIFN-a
until now, this research is the first example in the world that PoIFN-a is expressed by methylotrophic yeast system.
This research use recombinant plasmid PGEX-IFN as template, mature PoIFN-a gene was obtained by PCR method. The expression vector pPICZaA with the PoIFN-a gene was constructed by restrict enzyme digestion and ligation, then transformed into E.coli JM109 in order to extract recombinant plasmid from JM109. After DNA sequencing was correct, it was transformed into P.pastoris KM71H strain by electroporation. Highly resistant recombinant was isolated by increasing concentrations of Zeocin? positive clone was selected by PCR .The positive clone was induced with methanol . The results of SDS-PAGE and Western Blot showed that the product was recombinant PoIFN-a fusion protein. Biological activity of this fusion protein was detected by VSV/WISH system, the result was 4.104.1 104IU/m=
近年来，甲醇营养型酵母表达系统的研究得到迅速发展，因其具有高表达、高稳定、高分泌、能对表达的外源蛋白进行正确的折叠、加工，利于下游分离纯化操作、能大规模发酵生产等诸多优点，国内外已经利用此系统表达了多种对人类有益的动植物及微生物活性蛋白，但对猪α型干扰素的酵母表达还未见报导，本研究是国内外首次采用此系统表达猪α型干扰素。
本研究以猪α干扰素重组质粒PGEX-IFN为模板，运用常规PCR方法扩增得到猪α干扰素基因的成熟编码序列。将此基因与毕赤酵母分泌型表达载体pPICZαA连接，构建pPICZαA-IFN重组质粒，并用常规CaCl_2法转化大肠杆菌JM109进行扩增。提取重组质粒，酶切、PCR扩增和DNA序列分析鉴定阳性克隆。阳性重组质粒经纯化处理后用BioRad公司电转仪电转化毕赤酵母菌株KM71H。抗生素Zeocin~(TM)浓度梯度筛选高拷贝菌株，分别提取这些高拷贝菌株的基因组DNA，以此为模板做PCR反应鉴定阳性克隆。经上述实验过程筛选出的高拷贝重组菌株分别通过BMGY／BMMY培养基和YPG培养基、用甲醇诱导表达，诱导菌液上清
葛丽：猪a干扰素基因在毕赤酵母中的分泌表达
通过三氯醋酸沉淀蛋白处理，做 SDS－PAGE和 West。印迹实验，结果表
明表达产物为重组猪口干扰素融合蛋白。将筛选出来的重组菌株诱导144
小时，取菌液上清液用VSV／WISH系统检测重组蛋白的抗病毒活性为
4．l＊I04lU／ffiL o
Interferon (IFN), a family of cytokines, have activities on interfering with the replication of various viruses, decreasing cell proliferation and modifying immunological processes. The research about IFN indicates, it is a kind of ideal therapy that IFN act on healthy or unhealthy animals to prevent or cure many kinds of diseases infected by virus. However, animal organisms could not produce IFN commonly, many scholars had attempted to use virus infect animals in order to induce leukocyte to produce IFN. As a result, a very small quantity of IFN was produced and also the cost of production was very high, it was difficult to extract and purify IFN protein. With the development of DNA recombination technology, there are also some reports about the expression of recombined IFN protein by prokaryotic expression system, but the expressed
proteins often consist in the form of inclusion body= The operations about extracting and purifying proteins are very complicated, biological activity of proteins are not high. Therefore, this research is the first time to attempt to express porcine IFN-a(PoIFN-a) by eukaryotic expression system.
Recently, the expression system of methylotrophic yeast has been developed quickly. As a result of its many advantages, such as high expression, high stability, high secretion and so on, many kinds of Protein, including animal, plant, microorganism proteins, have been expressed by this system in the world, but we have not seen any report about yeast expression of PoIFN-a
until now, this research is the first example in the world that PoIFN-a is expressed by methylotrophic yeast system.
This research use recombinant plasmid PGEX-IFN as template, mature PoIFN-a gene was obtained by PCR method. The expression vector pPICZaA with the PoIFN-a gene was constructed by restrict enzyme digestion and ligation, then transformed into E.coli JM109 in order to extract recombinant plasmid from JM109. After DNA sequencing was correct, it was transformed into P.pastoris KM71H strain by electroporation. Highly resistant recombinant was isolated by increasing concentrations of Zeocin? positive clone was selected by PCR .The positive clone was induced with methanol . The results of SDS-PAGE and Western Blot showed that the product was recombinant PoIFN-a fusion protein. Biological activity of this fusion protein was detected by VSV/WISH system, the result was 4.104.1 104IU/m=
引文
[1] 蔡传奇，方荣祥．毕赤酵母基因操作技术的改进及其在水蛭素表达中的应用．生物工程学报，2001，17(2)：155～160．
[2] 陈国华，朱耀华，陈洪明等：干扰素对猪腹泻病的治疗实验．上海畜牧兽医通讯，1995，3，22～23．
[3] 邓兵兵，方宏清，薛冲等．人肝细胞生长因子基因在毕赤酵母中的分泌表达．中国生物化学与分子生物学报，2001，17(5)：590～594．
[4] 丁敦志．猪白细胞干扰素诱生条件的研究．四川畜牧兽医，1996，3(1)：20～21．
[5] 丁敦志．猪白细胞干扰素效价测定方法的探讨．四川畜牧兽医，1996，12(4)：20～21。
[6] 丁云菲，刘勇，刘红岩等．分泌型乙型肝炎病毒包膜M蛋白在毕赤酵母中的表达．中国生物化学与分子生物学报，2002，18(3)：265～271．
[7] 范乔，刘宏迪．甲醇营养型酵母表达外源蛋白的特点及策略．微生物学通报，1996，26(4)：304～306．
[8] 郭赢军．猪干扰素在大肠杆菌中的克隆与表达．生物工程学报，2001，17(2)：183～186．
[9] 何诚，朱运松．甲醇营养型酵母表达系统的研究进展．生物工程进展，1998，18(3)：7～11．
[10] 侯云德．分子病毒学．北京：文苑出版社，1990，237～246．
[11] 江正兵，宋慧婷，马立新．短小芽孢杆菌木聚糖酶基因在毕赤酵母中的分泌表达及酶学性质研究．生物工程学报，2003，19(1)：50～55．
[12] 李晶，赵晓祥，沙长青等．甲醇酵母基因表达系统的研究进展．生物工程进展，1999，19(2)：17～20．
[13] 李江，魏开坤，马学军等．新型人干扰素α_(1c)的纯化和活性测定．细胞与分子免疫学杂志，2001，17(1)：79～81．
[14] 李克勤，李春海，颜春洪．人组织型基质金属蛋白酶抑制剂-1在Pichia pastofis酵母中重组表达研究．中国生物化学与分子生物学报，2001，17(2)：160～164．
[15] 李文清，何明，罗进贤．黑曲霉葡萄淀粉酶基因在酿酒酵母中的表达和分泌．中国科学B辑，1994，24(9)：942～945．
[16] 李欣，郭树华．影响外源基因在巴氏毕赤酵母中表达的因素．生物技术通讯，2000，11(2)：132～135．
[17] 李育阳．外源基因在酵母中表达产物的分泌．生物工程学报，1987，3(2)：81～83．
[18] 李育阳．基因表达技术．北京科学出版社，2001，2．
[19] 刘麟，陈宇光，谈立松等．人血管内皮细胞生长抑制因子在巴斯德毕赤酵母中的分泌表达．生物技术通讯，2001，12(2)：85～87．
[20] 刘万均，胡景韶，张道永等．用猪白细胞干扰素防治猪流行性腹泻．中国兽医科技，1996，26(2)：27～28．
[21] 刘文，胡巍，王洪海．酵母表达基因工程产物特性分析．生物工程进展，2001，21(2)：74～76．
[22] 罗经，杨学楼．猪干扰素的某些性质．国外医学：免疫学分册，1980，12(5)：252～255．
[23] Moore B．R．干扰素在大家畜临床上的应用．国外兽医学—畜禽传染病，1995，73(3)：18～22．
[24] 马兴元，谭建华，朱平等．巴斯德毕赤酵母(Pichia pastoris)表达系统及其在外源蛋白生产中的优势与应用前景．中国兽医学报，2003，23(1)：98～101．
[25] 宁春玲．干扰素的临床应用研究进展．齐齐哈尔医学院学报，2000，21(3)：338～341．
[26] 欧阳立明，张惠展，张嗣良等．巴斯德毕赤酵母的基因表达系统研究进展．生物化学与生物物理进展，2000，27(2)：151～154．
[27] 欧阳石文，冯兰香，谢丙炎；芥菜新型几丁质酶基因在毕赤酵母(Pichia pastoris)中的分泌表达．农业生物技术学报，2002，10(1)：33～35．
[28] 彭毅，步威，康良仪．甲醇酵母表达系统．生物技术通报，2000，1：38～41．
[29] 唐南筠，霍克克，李育阳．乳酸克鲁维酵母高拷贝整合载体的构建和应用．生物化学和生物物理学报，1996，28(5)：540～545．
[30] 涂宣林，宋后燕．P.pastoris高效表达外源蛋白的研究进展．生物工程进展，1998，18(4)：19～22．
[31] 王桂玉，刘润梅，潘善培等．重组质粒Ppicz9K-oLHαhCGβCTP的构建及在毕赤酵母中的表达。中国生物化学与分子生物学报，1999，15(2)：175～178．
[32] 王伟，侯云德．人α型干扰素突变体(IFN-α1／86D)的组建及其生物活性的研究．病毒学报，1990，6(4)：322～325．
[33] 王洪海，高卜渝，陈佩丽等．酵母表达基因工程产物不均一性分析及对策．中国科学B辑，1994，24(12)：127～129．
[34] 夏春，刘津，杨琪等．猪干扰素β基因的分子克隆与测序．中国兽医杂志，2000，26(6)：6～7．
[35] 夏春，汪明，蒋金书等．猪干扰素IFN与IFN基因克隆及其生物发酵体系．大连，中国畜牧兽医学会生物技术学分会、中国免疫学会兽医免疫学分会论文集，2000。
[36] 熊爱生，彭日荷，李贤等．信号肽序列对毕赤酵母表达外源蛋白质的
影响．生物化学与生物物理学报，2003，35(2)：154～160．
[37] 雄盛，罗勇，王一飞等．人源抗HbsAg单链抗体在巴氏毕赤酵母中的表达．生物工程学报，2003，19(1)：19～23．
[38] 徐耀先．分子病毒学．湖北科技技术出版社，2000，1：175～185．
[39] 杨晟，章如安，袁中一等．重组人血清白蛋白在Pichia pastoris中分泌表达因素的研究．生物工程学报，2000，16(6)：675～678．
[40] 赵翔，霍克克，李育阳．毕赤酵母的密码子用法分析．生物工程学报，2000，16(3)：308～311．
[41] 中国生物制品标准化委员会，中国生物制品规程，北京：化学工业出版社，2000，170：672～684．
[42] 张博润，刘建源．酵母菌的载体系统研究进展，微生物学通报，1998，25：42～44．
[43] 张明生，吴耕，钟晓力等．酵母表达体系及其在抗体工程中的应用．生物工程进展，2001，21(1)：15～18．
[44] 张应玖，金宁一，王宏伟等．HIV-2外膜蛋白在甲醇型酵母Pichia pastoris中的表达与鉴定．生物化学与生物物理学报，2001，33(4)：405～408．
[45] 张振龙，邓宛明，黄颖等．重组人干扰素β在大肠杆菌中的表达与活性分析．生物技术通讯，2001，12(3)：202～204．
[46] 章如安，杨晟，邱荣德等．巴斯德毕赤酵母表达系统研究及进展．微生物学通报，2000，27(5)：371～373．
[47] A Manual of Methods for Expression of Recombinant Proteins Using pPICZ and pPICZ α in Pichia pastoris,Invitrogen, 2002, 10～14.
[48] Ausubel F M,Brent R, Kingston R E, et al. Current Protocol in Molecular Biology New York: Greene Publishing Associates and Wiley-Interscience, 13.11.1
13.11.4.
[49] A W Thomson. The Cytokine Handbook.New York, 1994, 265～288.
[50] Bretthauer R K, Castellino F J.Review;Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem. 1999,30:193～200.
[51] Bruel C, Cha K, Reeves P J, et al. Rhodopsin kinase: expression in mammalian cells and a two-step purification[J]. Proc Natl Acad Sci USA,2000,97(7): 3004～3009.
[52] Bulter J S, Sadhale P P, Platt T.RNA produces mature 3' ends of a variety of Saccharomyces cerevisiae mRNAs. Mol Cell Biol, 1990,10:2599～2605.
[53] Cereghino J L, Cregg J M.Heterologous protein expression in the methylotrophic yeast Pichia pastoris[J]. FEMS Microbiol Rev,2000,24(1): 45-66.
[54] Clare JJ.Production of mouse epidermal growth factor in yeast high-level secretion using Pichia pastoris strains containing multiple gene copies. Gene, 1991.105:205～212.
[55] Clare JJ, Rayment FB, Ballantine S P, et al.High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integration of the gene[J]. Bio/Technology, 1991,9:455～460.
[56] Cregg JM, Vedvick T S, Raschke W C. Recent advances in the expression of foreigngenes in Pichia pastoris[J].Bio/Technology, 1993,11(8): 905～910.
[57] Cregg JM, Cereghino J L, Shi J, et al.Recombinant protein expression in Pichia pastoris[J].Mol Biotechnol,2000,16(1):23～52.
[58] Cregg JM, Tschopp JF, Stillman C, et al. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris.Biotechnology, 1987,5:479～483.
[59]Chung J D.Design of metabolic feed controllers:application to high-density fermentation of Pichia pastoris[J].Biotechnol Bioeng,2000,68(3):298～307.
[60]David R,Higgins, James M. Cregg. Methods in Molecular Biology, 1998, 103: 1～15.
[61]Eckart MR, Bussineau CM.Quality and authenticity of heterologous proteins synthesized in yeast. Curr Opin Biotechnol, 1996,7(5): 525～530.
[62]Egbert. P. Properties of Natural Porcine Interferons. J Interferon Res, 1988, 8, 61～73.
[63]Gemmill T R,Trimble R B.Overview of N-and O-linked oligosaccharide structures found in various yeast species.Biochim Biophys Aata, 1999,1426(2): 227～237.
[64]George R S, Ian M K, Bryan R G, et al. How Cells Respond to Interferons. Ann Rev Biochem, 1998, 67, 227～264.
[65]Gregg JM, Madden KR, Bamhager K J.Mol Cell. Biol. 1989;9:1316～1323.
[66]Gregg JM, Barringer K J, Hessler A Y,et al.Pichia pastoris as a host system for transformations[J].Mol Cell Biol, 1985,5:3376～3385.
[67]Grinna L S,Tschopp J F.Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast Pichia pastoris. Yeast, 1989,5(2): 107～115.
[68]Heckney R C.Recent developments in heterologous protein production in Escherichia coli[J].Trends Biotech, 1994,12(11): 456～463.
[69]Hollenberg CP, Gellissen G. Production of recombinant proteins by methylotrophic yeasts[J].Curr Opin Biotechnol, 1985,5:3376～3385.
[70]Hollenberg CP, Gellissen G. Production of recombinant proteins by
methylotrophic yeast. Curr Opin Biotechnol. 1997,8(5):554～560.
[71] Hoop MJ, de and AB G.Import of proteins into peroxisomes and other microbodies. Biochem J. 1992;286:657～669.
[72] Johnston MD,Finter NB,Young PA.Dye uptake method for assay of interferon activity[J].Methods Enzymol, 1981,78(2):394～398.
[73] Kjeldesen T, BRAANDT J, Andersen AS, et al.A removable spacer peptide in an α-factor-leader/insulin precursor fusion proteolytic degradation of secreted recombinant human albumin. Yeast, 1998,14: 161～169.
[74] Lefevre F, Bonnardiere C L. Molecular Cloning and Sequencing of a Gene Encoding Biologically Active Porcine α-Interferon. J Interferon Res, 1986, 6, 349～360.
[75] Lefevre F, L' haridon R, Borras-Cuesta F, et al. Production, purification and biological properties of an Escherichia coli-derived recombinant porcine alpha interferon. J Gert Vir, 1990, 71, 1057～1063.
[76] Linder S,Schliwa M,Kube-Granderath E.Direct PCR screening of Pichia pastoris clones.Biotechniques, 1996,20(6):980～982.
[77] Nascimento C, Stephans J C, Powers M A, et al.Antigenicity and immunogenicity of domains of the human immunodeficiency virus(HIV) envelope polypeptide expressed in the yeast Ssccharomyces cerevisiae[J].Vaccine, 1987,5:90～101.
[78] Nicaud JM, Raynal A, Beyou A, et al. Stabilization of methionine-rich protein in Saccharomyces cerevisiae:targeting of BIN protein into the peroxisome. Curr Genet. 1994; 26:390～397.
[79] Ostapchuk P, Hearing P, Ganem D.A dramatic shift in the transmenbrane topology of a viral envelope glycoprotein accompanies
hepatitis B viral morphogenesis.EMBO J, 1994,13:1048～1057.
[80] Pestka S, Langer J A. Interferons and their actions, Ann Rev Biochem, 1987, 56, 727～777.
[81] Pestka S, Meager A.Interferon standardization and designations[J].J Interferon Cytokine Res, 1997,17(Suppl 1):9～14.
[82] Peter L. Biochemistry of Interferons and Their Actions. Ann Rev Biochem, 1982, 51:251～282.
[83] Pfeffer LM, Dinarello CA, Ronald B, et al.Biological properties of recombinant α-interferon: 40th Anniversary of the Discovery of Interferon[J].Cancer Res, 1998,58(11):2489～2499.
[84] Philippe van den S, Pauline, Raymond, et al. Concepts and principles of O-linked glycosylation. Critical Reviews in Biochemistry and Mollec μ Lar Biology, 1998,33(3): 151～208.
[85] Rees G S, Gee C K.Rat tumcur necrosis factor-alpha:expression in recombinant Pichia pastoris,purification, characterization and development of a novel ELISA[J].Eur Cytokine Netw, 1999,10(3):383～392.
[86] Ridder, R..Gneration of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris.Bio/Technology, 1995,13:255～260.
[87] Rogelj B, Strukelj B, Bosch D, et al. Expression, purification,and characterization of equistation in Pichia pastoris[J].Protein Expr Purif,2000,19(3): 329～334.
[88] Romanos MA, Beesley JJ.Recombinant Bordetella pertussis pertaction from the yeast Pichia pastoris:high-level production and immunological properties.Vaccine, 1991,9:901～906.
[89] Romanos M.Advances in the use of Pichia pastoris for high-level gene expression. Current pinion in Biotechnology, 1995,6: 527～533.
[90] Sambrook J, Frisch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989,1～21.
[91] Scorer CA, Buckhoz R G, Clare JJ, et al. The intracellular production and secretion of HIV-lenvelope protein in the methylotrophic yeast Pichia pastoris[J].Gene, 1993,136:111～119.
[92] Scorer CA, Clare JJ.Rapid aelection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Bio/Technology, 1994,12:181～184.
[93] SHEN T(沈同), WANG J Y(王镜岩), ZHAAO B T(赵邦悌), et al.Biosynthesis of protein,In: SHEN T(沈同), ANG J Y (王镜岩)(ed), Biochemistry (生物化学), 2nd ed, Beijing: Higher Education Press, 1995, pp. 411～414.
[94] Southgate VJ, Steyn AJ, Pretorius IS, et al.Expression and secretion of Bacillus amyloliquefaciens alpha-amylase by using the yeast pheromone alpha-factor promoter and leader sequence in Saccharomyces cerevisiae. Appl Environ Microbiol, 1993, 59(4): 1253～1258.
[95] Sreekrishna K, Brankamp RG, Kropp KE, et al. Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris. Gene, 1997,190(1):55～62.
[96] Sreekrishna K, Nelles L, Potenz R, et al. High-level expression, purification,and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris. Biochemistry, 1989,28: 4117～4125.
[97] Stefan Schneider, Michael Buchert, Christopher M. Hovens,an in
vitro assay of β-galactosidase from yeast. Biotechniques, 1996,20:960～970.
[98] Subramani S.Ann. Protein import into peroxisomes and biogenesis of the organelle. Rev Cell Biol. 1993;9:445～478.
[99] Sudbery PE.The expression of recombinant proteins in yeasts. Curr Opin Biotechnol, 1996, 7(5): 517～524.
[100] Sugrue R J, Cui T, Xu Q, et al. The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris[J].Virol Methods, 1997,69(1-2): 159～169.
[101] Vander Klei I J, Harder W, Veenhuis M. Biosynthesis and assembly of alchol oxidase,a peroxisomal matrix protein in methylotrophic yeast: a review.Yeast, 1991,7(3): 195～209.
[102] Vassileva A, Arora Chugh D, Swaminathan S, et al.Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris[J]. Protein Expr Purif, 2001,21(1): 71～80.
[103] Veenhuis M. Peroxisome biogenesis and function in Hansenula polymorpha. Cell Biochem. Funct. 1992; 10:175～184.
[104] Veehuis M, Harder W. Microbodies. In Rose,and Harrison,JS(Eds).The yeast, Vol4,2nd Academic Press Limited,London, 1991, pp601～653.
[105] Ward A C. Rapid analysis of yeast transformants using colony-PCR,Bio Techniques, 1992,13 (3): 350～355.
[2] 陈国华，朱耀华，陈洪明等：干扰素对猪腹泻病的治疗实验．上海畜牧兽医通讯，1995，3，22～23．
[3] 邓兵兵，方宏清，薛冲等．人肝细胞生长因子基因在毕赤酵母中的分泌表达．中国生物化学与分子生物学报，2001，17(5)：590～594．
[4] 丁敦志．猪白细胞干扰素诱生条件的研究．四川畜牧兽医，1996，3(1)：20～21．
[5] 丁敦志．猪白细胞干扰素效价测定方法的探讨．四川畜牧兽医，1996，12(4)：20～21。
[6] 丁云菲，刘勇，刘红岩等．分泌型乙型肝炎病毒包膜M蛋白在毕赤酵母中的表达．中国生物化学与分子生物学报，2002，18(3)：265～271．
[7] 范乔，刘宏迪．甲醇营养型酵母表达外源蛋白的特点及策略．微生物学通报，1996，26(4)：304～306．
[8] 郭赢军．猪干扰素在大肠杆菌中的克隆与表达．生物工程学报，2001，17(2)：183～186．
[9] 何诚，朱运松．甲醇营养型酵母表达系统的研究进展．生物工程进展，1998，18(3)：7～11．
[10] 侯云德．分子病毒学．北京：文苑出版社，1990，237～246．
[11] 江正兵，宋慧婷，马立新．短小芽孢杆菌木聚糖酶基因在毕赤酵母中的分泌表达及酶学性质研究．生物工程学报，2003，19(1)：50～55．
[12] 李晶，赵晓祥，沙长青等．甲醇酵母基因表达系统的研究进展．生物工程进展，1999，19(2)：17～20．
[13] 李江，魏开坤，马学军等．新型人干扰素α_(1c)的纯化和活性测定．细胞与分子免疫学杂志，2001，17(1)：79～81．
[14] 李克勤，李春海，颜春洪．人组织型基质金属蛋白酶抑制剂-1在Pichia pastofis酵母中重组表达研究．中国生物化学与分子生物学报，2001，17(2)：160～164．
[15] 李文清，何明，罗进贤．黑曲霉葡萄淀粉酶基因在酿酒酵母中的表达和分泌．中国科学B辑，1994，24(9)：942～945．
[16] 李欣，郭树华．影响外源基因在巴氏毕赤酵母中表达的因素．生物技术通讯，2000，11(2)：132～135．
[17] 李育阳．外源基因在酵母中表达产物的分泌．生物工程学报，1987，3(2)：81～83．
[18] 李育阳．基因表达技术．北京科学出版社，2001，2．
[19] 刘麟，陈宇光，谈立松等．人血管内皮细胞生长抑制因子在巴斯德毕赤酵母中的分泌表达．生物技术通讯，2001，12(2)：85～87．
[20] 刘万均，胡景韶，张道永等．用猪白细胞干扰素防治猪流行性腹泻．中国兽医科技，1996，26(2)：27～28．
[21] 刘文，胡巍，王洪海．酵母表达基因工程产物特性分析．生物工程进展，2001，21(2)：74～76．
[22] 罗经，杨学楼．猪干扰素的某些性质．国外医学：免疫学分册，1980，12(5)：252～255．
[23] Moore B．R．干扰素在大家畜临床上的应用．国外兽医学—畜禽传染病，1995，73(3)：18～22．
[24] 马兴元，谭建华，朱平等．巴斯德毕赤酵母(Pichia pastoris)表达系统及其在外源蛋白生产中的优势与应用前景．中国兽医学报，2003，23(1)：98～101．
[25] 宁春玲．干扰素的临床应用研究进展．齐齐哈尔医学院学报，2000，21(3)：338～341．
[26] 欧阳立明，张惠展，张嗣良等．巴斯德毕赤酵母的基因表达系统研究进展．生物化学与生物物理进展，2000，27(2)：151～154．
[27] 欧阳石文，冯兰香，谢丙炎；芥菜新型几丁质酶基因在毕赤酵母(Pichia pastoris)中的分泌表达．农业生物技术学报，2002，10(1)：33～35．
[28] 彭毅，步威，康良仪．甲醇酵母表达系统．生物技术通报，2000，1：38～41．
[29] 唐南筠，霍克克，李育阳．乳酸克鲁维酵母高拷贝整合载体的构建和应用．生物化学和生物物理学报，1996，28(5)：540～545．
[30] 涂宣林，宋后燕．P.pastoris高效表达外源蛋白的研究进展．生物工程进展，1998，18(4)：19～22．
[31] 王桂玉，刘润梅，潘善培等．重组质粒Ppicz9K-oLHαhCGβCTP的构建及在毕赤酵母中的表达。中国生物化学与分子生物学报，1999，15(2)：175～178．
[32] 王伟，侯云德．人α型干扰素突变体(IFN-α1／86D)的组建及其生物活性的研究．病毒学报，1990，6(4)：322～325．
[33] 王洪海，高卜渝，陈佩丽等．酵母表达基因工程产物不均一性分析及对策．中国科学B辑，1994，24(12)：127～129．
[34] 夏春，刘津，杨琪等．猪干扰素β基因的分子克隆与测序．中国兽医杂志，2000，26(6)：6～7．
[35] 夏春，汪明，蒋金书等．猪干扰素IFN与IFN基因克隆及其生物发酵体系．大连，中国畜牧兽医学会生物技术学分会、中国免疫学会兽医免疫学分会论文集，2000。
[36] 熊爱生，彭日荷，李贤等．信号肽序列对毕赤酵母表达外源蛋白质的
影响．生物化学与生物物理学报，2003，35(2)：154～160．
[37] 雄盛，罗勇，王一飞等．人源抗HbsAg单链抗体在巴氏毕赤酵母中的表达．生物工程学报，2003，19(1)：19～23．
[38] 徐耀先．分子病毒学．湖北科技技术出版社，2000，1：175～185．
[39] 杨晟，章如安，袁中一等．重组人血清白蛋白在Pichia pastoris中分泌表达因素的研究．生物工程学报，2000，16(6)：675～678．
[40] 赵翔，霍克克，李育阳．毕赤酵母的密码子用法分析．生物工程学报，2000，16(3)：308～311．
[41] 中国生物制品标准化委员会，中国生物制品规程，北京：化学工业出版社，2000，170：672～684．
[42] 张博润，刘建源．酵母菌的载体系统研究进展，微生物学通报，1998，25：42～44．
[43] 张明生，吴耕，钟晓力等．酵母表达体系及其在抗体工程中的应用．生物工程进展，2001，21(1)：15～18．
[44] 张应玖，金宁一，王宏伟等．HIV-2外膜蛋白在甲醇型酵母Pichia pastoris中的表达与鉴定．生物化学与生物物理学报，2001，33(4)：405～408．
[45] 张振龙，邓宛明，黄颖等．重组人干扰素β在大肠杆菌中的表达与活性分析．生物技术通讯，2001，12(3)：202～204．
[46] 章如安，杨晟，邱荣德等．巴斯德毕赤酵母表达系统研究及进展．微生物学通报，2000，27(5)：371～373．
[47] A Manual of Methods for Expression of Recombinant Proteins Using pPICZ and pPICZ α in Pichia pastoris,Invitrogen, 2002, 10～14.
[48] Ausubel F M,Brent R, Kingston R E, et al. Current Protocol in Molecular Biology New York: Greene Publishing Associates and Wiley-Interscience, 13.11.1
13.11.4.
[49] A W Thomson. The Cytokine Handbook.New York, 1994, 265～288.
[50] Bretthauer R K, Castellino F J.Review;Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem. 1999,30:193～200.
[51] Bruel C, Cha K, Reeves P J, et al. Rhodopsin kinase: expression in mammalian cells and a two-step purification[J]. Proc Natl Acad Sci USA,2000,97(7): 3004～3009.
[52] Bulter J S, Sadhale P P, Platt T.RNA produces mature 3' ends of a variety of Saccharomyces cerevisiae mRNAs. Mol Cell Biol, 1990,10:2599～2605.
[53] Cereghino J L, Cregg J M.Heterologous protein expression in the methylotrophic yeast Pichia pastoris[J]. FEMS Microbiol Rev,2000,24(1): 45-66.
[54] Clare JJ.Production of mouse epidermal growth factor in yeast high-level secretion using Pichia pastoris strains containing multiple gene copies. Gene, 1991.105:205～212.
[55] Clare JJ, Rayment FB, Ballantine S P, et al.High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integration of the gene[J]. Bio/Technology, 1991,9:455～460.
[56] Cregg JM, Vedvick T S, Raschke W C. Recent advances in the expression of foreigngenes in Pichia pastoris[J].Bio/Technology, 1993,11(8): 905～910.
[57] Cregg JM, Cereghino J L, Shi J, et al.Recombinant protein expression in Pichia pastoris[J].Mol Biotechnol,2000,16(1):23～52.
[58] Cregg JM, Tschopp JF, Stillman C, et al. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris.Biotechnology, 1987,5:479～483.
[59]Chung J D.Design of metabolic feed controllers:application to high-density fermentation of Pichia pastoris[J].Biotechnol Bioeng,2000,68(3):298～307.
[60]David R,Higgins, James M. Cregg. Methods in Molecular Biology, 1998, 103: 1～15.
[61]Eckart MR, Bussineau CM.Quality and authenticity of heterologous proteins synthesized in yeast. Curr Opin Biotechnol, 1996,7(5): 525～530.
[62]Egbert. P. Properties of Natural Porcine Interferons. J Interferon Res, 1988, 8, 61～73.
[63]Gemmill T R,Trimble R B.Overview of N-and O-linked oligosaccharide structures found in various yeast species.Biochim Biophys Aata, 1999,1426(2): 227～237.
[64]George R S, Ian M K, Bryan R G, et al. How Cells Respond to Interferons. Ann Rev Biochem, 1998, 67, 227～264.
[65]Gregg JM, Madden KR, Bamhager K J.Mol Cell. Biol. 1989;9:1316～1323.
[66]Gregg JM, Barringer K J, Hessler A Y,et al.Pichia pastoris as a host system for transformations[J].Mol Cell Biol, 1985,5:3376～3385.
[67]Grinna L S,Tschopp J F.Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast Pichia pastoris. Yeast, 1989,5(2): 107～115.
[68]Heckney R C.Recent developments in heterologous protein production in Escherichia coli[J].Trends Biotech, 1994,12(11): 456～463.
[69]Hollenberg CP, Gellissen G. Production of recombinant proteins by methylotrophic yeasts[J].Curr Opin Biotechnol, 1985,5:3376～3385.
[70]Hollenberg CP, Gellissen G. Production of recombinant proteins by
methylotrophic yeast. Curr Opin Biotechnol. 1997,8(5):554～560.
[71] Hoop MJ, de and AB G.Import of proteins into peroxisomes and other microbodies. Biochem J. 1992;286:657～669.
[72] Johnston MD,Finter NB,Young PA.Dye uptake method for assay of interferon activity[J].Methods Enzymol, 1981,78(2):394～398.
[73] Kjeldesen T, BRAANDT J, Andersen AS, et al.A removable spacer peptide in an α-factor-leader/insulin precursor fusion proteolytic degradation of secreted recombinant human albumin. Yeast, 1998,14: 161～169.
[74] Lefevre F, Bonnardiere C L. Molecular Cloning and Sequencing of a Gene Encoding Biologically Active Porcine α-Interferon. J Interferon Res, 1986, 6, 349～360.
[75] Lefevre F, L' haridon R, Borras-Cuesta F, et al. Production, purification and biological properties of an Escherichia coli-derived recombinant porcine alpha interferon. J Gert Vir, 1990, 71, 1057～1063.
[76] Linder S,Schliwa M,Kube-Granderath E.Direct PCR screening of Pichia pastoris clones.Biotechniques, 1996,20(6):980～982.
[77] Nascimento C, Stephans J C, Powers M A, et al.Antigenicity and immunogenicity of domains of the human immunodeficiency virus(HIV) envelope polypeptide expressed in the yeast Ssccharomyces cerevisiae[J].Vaccine, 1987,5:90～101.
[78] Nicaud JM, Raynal A, Beyou A, et al. Stabilization of methionine-rich protein in Saccharomyces cerevisiae:targeting of BIN protein into the peroxisome. Curr Genet. 1994; 26:390～397.
[79] Ostapchuk P, Hearing P, Ganem D.A dramatic shift in the transmenbrane topology of a viral envelope glycoprotein accompanies
hepatitis B viral morphogenesis.EMBO J, 1994,13:1048～1057.
[80] Pestka S, Langer J A. Interferons and their actions, Ann Rev Biochem, 1987, 56, 727～777.
[81] Pestka S, Meager A.Interferon standardization and designations[J].J Interferon Cytokine Res, 1997,17(Suppl 1):9～14.
[82] Peter L. Biochemistry of Interferons and Their Actions. Ann Rev Biochem, 1982, 51:251～282.
[83] Pfeffer LM, Dinarello CA, Ronald B, et al.Biological properties of recombinant α-interferon: 40th Anniversary of the Discovery of Interferon[J].Cancer Res, 1998,58(11):2489～2499.
[84] Philippe van den S, Pauline, Raymond, et al. Concepts and principles of O-linked glycosylation. Critical Reviews in Biochemistry and Mollec μ Lar Biology, 1998,33(3): 151～208.
[85] Rees G S, Gee C K.Rat tumcur necrosis factor-alpha:expression in recombinant Pichia pastoris,purification, characterization and development of a novel ELISA[J].Eur Cytokine Netw, 1999,10(3):383～392.
[86] Ridder, R..Gneration of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris.Bio/Technology, 1995,13:255～260.
[87] Rogelj B, Strukelj B, Bosch D, et al. Expression, purification,and characterization of equistation in Pichia pastoris[J].Protein Expr Purif,2000,19(3): 329～334.
[88] Romanos MA, Beesley JJ.Recombinant Bordetella pertussis pertaction from the yeast Pichia pastoris:high-level production and immunological properties.Vaccine, 1991,9:901～906.
[89] Romanos M.Advances in the use of Pichia pastoris for high-level gene expression. Current pinion in Biotechnology, 1995,6: 527～533.
[90] Sambrook J, Frisch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989,1～21.
[91] Scorer CA, Buckhoz R G, Clare JJ, et al. The intracellular production and secretion of HIV-lenvelope protein in the methylotrophic yeast Pichia pastoris[J].Gene, 1993,136:111～119.
[92] Scorer CA, Clare JJ.Rapid aelection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Bio/Technology, 1994,12:181～184.
[93] SHEN T(沈同), WANG J Y(王镜岩), ZHAAO B T(赵邦悌), et al.Biosynthesis of protein,In: SHEN T(沈同), ANG J Y (王镜岩)(ed), Biochemistry (生物化学), 2nd ed, Beijing: Higher Education Press, 1995, pp. 411～414.
[94] Southgate VJ, Steyn AJ, Pretorius IS, et al.Expression and secretion of Bacillus amyloliquefaciens alpha-amylase by using the yeast pheromone alpha-factor promoter and leader sequence in Saccharomyces cerevisiae. Appl Environ Microbiol, 1993, 59(4): 1253～1258.
[95] Sreekrishna K, Brankamp RG, Kropp KE, et al. Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris. Gene, 1997,190(1):55～62.
[96] Sreekrishna K, Nelles L, Potenz R, et al. High-level expression, purification,and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris. Biochemistry, 1989,28: 4117～4125.
[97] Stefan Schneider, Michael Buchert, Christopher M. Hovens,an in
vitro assay of β-galactosidase from yeast. Biotechniques, 1996,20:960～970.
[98] Subramani S.Ann. Protein import into peroxisomes and biogenesis of the organelle. Rev Cell Biol. 1993;9:445～478.
[99] Sudbery PE.The expression of recombinant proteins in yeasts. Curr Opin Biotechnol, 1996, 7(5): 517～524.
[100] Sugrue R J, Cui T, Xu Q, et al. The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris[J].Virol Methods, 1997,69(1-2): 159～169.
[101] Vander Klei I J, Harder W, Veenhuis M. Biosynthesis and assembly of alchol oxidase,a peroxisomal matrix protein in methylotrophic yeast: a review.Yeast, 1991,7(3): 195～209.
[102] Vassileva A, Arora Chugh D, Swaminathan S, et al.Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris[J]. Protein Expr Purif, 2001,21(1): 71～80.
[103] Veenhuis M. Peroxisome biogenesis and function in Hansenula polymorpha. Cell Biochem. Funct. 1992; 10:175～184.
[104] Veehuis M, Harder W. Microbodies. In Rose,and Harrison,JS(Eds).The yeast, Vol4,2nd Academic Press Limited,London, 1991, pp601～653.
[105] Ward A C. Rapid analysis of yeast transformants using colony-PCR,Bio Techniques, 1992,13 (3): 350～355.